Hypertension Trial, Recruiting (NCT07158047)

Hypertension Trial, Recruiting NCT07158047 Sponsor: University of Oregon Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07158047 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with a body mass index (BMI) between 30 and 45, which is a measure of body weight relative to height

Who may not be able to join:

People who have been diagnosed with diabetes
People with high blood pressure that is classed as higher than stage 2 (confirm with trial site)
People with blood clotting disorders
People with an allergy to lidocaine, a type of local anaesthetic
People who are currently taking medications that affect blood pressure, blood clotting, or blood sugar levels
People who smoke
People who are pregnant
People who are planning to become pregnant in the near future
People who are currently breastfeeding
People with a BMI below 30 or above 45
People who exercise more than 120 minutes per week
People who are currently taking any medications, other than hormonal contraceptives (such as the pill)
People who are not willing to stop taking medications (other than hormonal contraceptives) for 24 hours before test days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher T Minson, PhD, University of Oregon

Phone: 541-346-7583

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07158047

Sponsor: University of Oregon

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 541-346-7583

More information: https://clinicaltrials.gov/study/NCT07158047

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People with a body mass index (BMI) between 30 and 45, which is a measure of body weight relative to height

Who may not be able to join:

People who have been diagnosed with diabetes
People with high blood pressure that is classed as higher than stage 2 (confirm with trial site)
People with blood clotting disorders
People with an allergy to lidocaine, a type of local anaesthetic
People who are currently taking medications that affect blood pressure, blood clotting, or blood sugar levels
People who smoke
People who are pregnant
People who are planning to become pregnant in the near future
People who are currently breastfeeding
People with a BMI below 30 or above 45
People who exercise more than 120 minutes per week
People who are currently taking any medications, other than hormonal contraceptives (such as the pill)
People who are not willing to stop taking medications (other than hormonal contraceptives) for 24 hours before test days

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Oregon

Registry

ClinicalTrials.gov

Start date

7 March 2022

Est. completion

30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Blood pressure change; Blood glucose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov